No new Ozempic scripts: TGA

Prescribers urged not to start new patients on Ozempic, as Novo Nordisk warns of supply shortages throughout 2024  Ozempic supplier, Novo Nordisk, is warning that supply of the diabetes medication will be limited for the rest of this year and throughout 2024, due to accelerated demand in recent months.   In response to the supply

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Private label to drive retail growth: Sigma
Next Immune health: the impact of Covid